Connect with us

Business

Recce (ASX:RCE) share price edges lower following study delays

Published

on

Image source: Getty Images

The Recce Pharmaceuticals Ltd (ASX: RCE) share price is falling after the company released an update on its clinical pipeline. In afternoon trade, shares in Recce Pharmaceuticals are trading 0.46% lower at $1.08.

The update announced delays to the…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending